Understanding the Difference Between Hyperdiploid and Hypodiploid Multiple Myeloma Cells

Medically Reviewed
SurvivorNet Fact Checking and Medical Review Standards:   The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts. All SurvivorNet articles adhere to the following standards:
  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles
6) Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated February 11th, 2022

Understanding the Difference Between Hyperdiploid and Hypodiploid Multiple Myeloma Cells


Patient Pathfinder

We’re here to help. Have you had any treatment for myeloma yet?

You might want to check out some top experts outlining the initial treatment for myeloma.

Got it. Are you looking for maintenance treatment?

You might want to check out some top experts outlining maintenance treatment for myeloma.

Ok. Has your Myeloma come back? Here are some useful resources:

If you’ve had at least four treatments that have not worked or stopped working you might be a candidate for a treatment called CAR T Therapy.

Learn How to Build Trust and Reduce Racial Disparities in Multiple Myeloma
Fighting For Multiple Myeloma Patients in Desperate Need: The Commitment From Johnson & Johnson's Blood Cancer Leader
26-Year-Old Woman, Whose Mole Developed Into 20 Tumors, Urges Skin Cancer Screenings After Stage Four Melanoma Diagnosis
56-Year-Old Mom of Two's Constant & Painful 'Intense Tingling' Turned Out To Be Blood Cancer
Patient Education is Key - Head of Hematology at Johnson & Johnson On Getting Multiple Myeloma Patients Access to Good Information & Care
Promising Targeted Therapy, Padcev, Falls Short of Meeting Goals for Advanced Breast Cancer - But May Still Have Future Treating Disease

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... multiple myeloma trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...


Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider